Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jalal Dahham
Observed name:
Dahham, Jalal
Institution:
Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban
Observed institutions:
Maastricht University,
Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban,
Care and Public Health Research Institute
ORCID:
0000-0002-2875-124X
Observed ORCID:
0000-0002-2875-124X
OpenAlex ID:
A5073326109
Economic Burden of Multiple Sclerosis in Low- and Middle‐Income Countries: A Systematic Review
2021
·
Jalal Dahham
, Rana Rizk
, et al.
·
PharmacoEconomics
·
72
PDF
Economic evaluation guidelines in low- and middle-income countries: a systematic review
2021
·
Caroline Daccache
, Rana Rizk
, et al.
·
International Journal of Technology Assessment in Health Care
·
50
PDF
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
2022
·
Jalal Dahham
, Ingrid Kremer
, et al.
·
Applied Health Economics and Health Policy
·
27
PDF
The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol
2021
·
Jalal Dahham
, Rana Rizk
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
13
PDF
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study
2023
·
Jalal Dahham
, Mickaël Hiligsmann
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
9
PDF
Health-related quality of life and utilities among Lebanese patients with Multiple Sclerosis: A cross-sectional study
2024
·
Jalal Dahham
, Mickaël Hiligsmann
, et al.
·
Multiple Sclerosis and Related Disorders
·
7
PDF
Economic burden of multiple sclerosis in low- and middle-income countries: A case study from Lebanon
2023
·
Jalal Dahham
·
Research Publications (Maastricht University)
·
3
Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice
2025
·
Katia Iskandar
, Christine Roques
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
1
Economics perspectives on understanding antimicrobial use and resistance: a scoping review from theory to practice
2025
·
Iskandar, Katia
, Roques, Christine
, et al.
·
Figshare
·
1
Quality of life in patients with epilepsy in the context of socioeconomic challenges in Lebanon
2026
·
Samar Younes
, Chadia Haddad
, et al.
·
Quality of Life Research
Socioeconomic, Professional, and Leisure-Related Burden of Epilepsy Among Adults in Lebanon
2026
·
Younes, Samar
, Mourad, Nisreen
, et al.
·
HAL
Medication Access Crisis and Safety Concerns in Patients with Epilepsy in Lebanon
2026
·
Younes, Samar
, Mourad, Nisreen
, et al.
·
HAL
Quality of Life in Patients with Epilepsy in Lebanon: The Impact of Socioeconomic Challenges
2026
·
Younes, Samar
, Haddad, Chadia
, et al.
·
HAL
Healthcare Resource Utilisation among Patients with Epilepsy in Lebanon: Patterns of Care, Antiseizure Medication Use, and the Role of Seizure Recurrence
2026
·
Younes, Samar
, Dahham, Jalal
, et al.
·
HAL
Depressive symptoms in Lebanese patients with epilepsy: the role of antiseizure medication shortage and socioeconomic adversity
2026
·
Younes, Samar
, Haddad, Chadia
, et al.
·
HAL
Itinéraires de soins et accès aux traitements de la migraine au Liban : expériences et défis
2026
·
Nisreen Mourad
, Jalal Dahham
, et al.
·
Revue Neurologique
Strategies for improving the quality of caregiving in Qatar
2025
·
Lynne Kennedy
, Nathan Boucher
, et al.
·
Eastern Mediterranean Health Journal
PDF
Migraine management in Lebanon: Assessing economic, clinical and digital perspectives on patient care and innovation
2025
·
Mourad, Nisreen
, Younes, Samar
, et al.
·
HAL
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study
2023
·
Dahham, Jalal
, Hiligsmann, Mickaël
, et al.
·
Figshare
Show more works
View as search
Works count:
23
Citation count:
183
H-index:
6
I10-index:
4
Year
Topic
Type